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ABSTRACT 
 
Crohn’s Disease (CD) is an inflammatory disorder of the intestines caused by a 
dysregulated immune response to resident gut bacteria. Presently, most treatments for CD 
suppress the host immune system, which can lead to adverse side effects such as 
increased susceptibility to infections and malignancy. Hence, low-risk alternative 
treatment options are needed. Studies suggest that defects in Paneth cells (PCs) contribute 
to CD pathogenesis. PCs are specialized intestinal epithelial cells that regulate the gut 
microbiota through the secretion of antimicrobial peptides (AMPs). However, the 
reciprocal impact of the gut microbiota, as well as the role of the underlying intestinal 
stroma on PC function is still unclear. We hypothesized that microbes induce PC AMP 
expression through signaling from sub-epithelial stromal tissue of the intestines. To test 
this hypothesis, we compared the abundance of selected PC AMP mRNAs between 
specific pathogen free (SPF) mice that have a normal gut microbiota, and germ-free (GF) 
mice that have a sterile gut. AMP transcript levels were also compared in an in vitro 
system (enteroids) cultured from SPF and GF epithelial cells. The enteroid system is 
devoid of underlying stroma and bacteria, and thus provides a model to study the impact 
of these components on PC function. In vivo, AMP expression was significantly higher in 
SPF small intestine tissue than in GF tissue. However, in vitro, AMP expression in SPF 
enteroids decreased to that of GF enteroids over time. Interestingly, with the addition of 
sub-epithelial tissue to the enteroid system, AMP expression in SPF enteroids was 
restored to our in vivo measurements. In contrast, the addition of bacterial products (such 
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as LPS) without sub-epithelial tissue did not induce AMP expression. Based on these 
findings, we conclude that the sub-epithelial tissue is required for appropriate PC AMP 
expression. Given the reduction of AMP expression in GF mice, it is possible that the 
commensal microbiota regulate AMP expression of the PCs, through signaling from the 
sub-epithelial tissue. This work also highlights the limitations of the enteroid system 
when studying PC function since the simplified culture conditions neglect possible 
interactions with the underlying stroma and bacterial ligands. Hence, this limitation 
should be taken into consideration when using enteroids for future PC studies in CD.  
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INTRODUCTION 
 
Inflammatory bowel disease, also known as IBD, is a chronic inflammatory 
disease of the gastrointestinal tract. There are two major subtypes of IBD: Crohn’s 
disease (CD) and ulcerative colitis (UC) 2. Although these two subtypes may have 
overlapping symptoms, they each affect a different region of the gastrointestinal (GI) 
tract - ulcerative colitis is limited to the colon, while CD can affect any part of the 
gastrointestinal tract, though it is usually found in the distal portion of the small intestine 
16. Our lab is interested in understanding the underlying mechanisms in Crohn’s disease, 
and therefore the focus of this project is on the small intestine. 
 Most CD patients develop symptoms of abdominal pain, diarrhea, and loss of 
appetite. Unlike many other inflammatory diseases, CD tends to emerge during 
adolescence or in early adulthood. Since CD is chronic, the severity of most symptoms 
fluctuates over time and can be accompanied with delayed puberty, decrease in bone 
density and eventually culminate into an overall decrease in a patient’s quality of life 15. 
Even though it affects nearly 1.4 million Americans, the cure for CD is yet to be 
discovered. Over the years, the only treatment widely used today involves suppressing 
the immune system of the patient 3. However, this is not ideal, as it can result in increased 
adverse effects in patients such as reduced ability to fight infections and increased 
susceptibility to cancer.  
Alternative treatment options with lower side effects can be developed by 
manipulating one of the key players in Crohn’s Disease—Paneth cells (PCs). PCs are 
thought to play a role in some intestinal bowel diseases such as Crohn's disease. These 
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specialized cells are found throughout the small intestine and reside in the base of the 
crypts of Lieberkuhn in the intestine. These cells produce antimicrobial peptides (AMPs), 
a class of natural antibiotics made by the body that protects the host by disrupting the 
membranes of bacterial pathogens. In addition to regulating pathogens, AMPs also help 
regulate the normal, commensal bacteria that inhabit the GI tract and provide enteric 
homeostasis to maintain normal intestinal physiology. 
        In the case of CD patients, the host immune system mounts an exaggerated 
response to the commensal bacteria of the gut, indicating a possible role of PCs in CD. 
Nevertheless, the precise responsibility of these cells in CD is yet to be understood, due 
to the lack of in vitro systems to study PCs. Recently, however, an ex vivo system has 
been developed to enable the culture of intestinal crypts that contain primary intestinal 
epithelial cells including PCs 11. In this system, freshly isolated intestinal crypts are 
obtained from mouse or human tissue and are plated in Matrigel media with growth 
factors under sterile conditions. These crypts form spherical organoids called enteroids, 
which contain all differentiated cell types of the small intestine, and contain crypts 
organized around a central lumen (Fig. 1) 10, 14.  Enteroids can be frozen and cultured for 
over eight months.  Ultimately, it may be possible to study PC function through this 
enteroid system to clarify the role of these cells in CD and to test potential therapies that 
could enhance PC function in IBD patients. 
 Before using enteroids to study PC function, further investigation is necessary to 
determine if the enteroid system re-creates what is taking place in vivo. For example, in 
the mammalian intestine, resident enteric bacteria are an important factor for homeostasis 
and play a critical role regulating gut physiology. Some of these processes include 
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maintaining immune homeostasis and prevention of inflammation. However, enteroids 
must be grown in sterile system, devoid of microorganisms that could potentially 
overgrow the culture. Additionally, the enteroids contain solely the intestinal epithelium. 
Thus, the host intestinal stroma, such as the sub-epithelial tissue, is absent in this in vitro 
system (Fig. 2) 7. In this study, I hypothesize that the commensal gut microbiota regulates 
PC function through signaling from the sub-epithelial tissue. This is important because it 
can then provide information regarding the role of the microbiota as well as the 
underlying intestinal stroma on PC function. 
 
 	 
 
Figure 1.  Isolated intestinal crypts from murine jejunum (A). In cell culture, the crypts 
develop buds to form enteroids (B) 14. Image	from	Stelzner	et	al.,	2012. 	 
 
 
 
 
 
Figure 2.  H&E stained jejunal section with all the tissue layers intact (A).  H&E stained 
sub-epithelial tissue of the jejunal section (B).  Images courtesy of Susan Henning. 
A. B
A. B
Buds	
Lumen	
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METHODS 
 
Mice 
 Adult, wild-type C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME) were housed in 
SPF or germ-free (GF) conditions consistent with guidelines established by the American 
Association for Laboratory Animal Care and Research. SPF mice were bred for multiple 
generations in the same animal room and sacrificed within 8-12 weeks of age. Sterilely-
derived B6 mice were maintained in GF conditions at the National Gnotobiotic Rodent 
Resource Center at the University of North Carolina at Chapel Hill. 
 
Histology and PC enumeration 
1.5 cm sections of jejunum were fixed in 10% phosphate buffered formalin for 48 hours 
and were placed in paraffin longitudinally. These sections were then cut into 5 µm and 
stained using hematoxylin and eosin (H&E). The H&E slides were then observed under a 
bright field microscope for assessment. Crypts with an intact lumen were considered for 
enumeration. The number of PC in each location was recorded, by counting the 
granulated eosinophilic cells, for at least 10 crypt/villus units per section.  
 
 
 
 
 
Figure 3: Histological stain of jejunal section depicting Paneth cells.  
 
Paneth	cells	seen	as	granulated	eosinophilic	cells	
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Small intestine morphology  
Using Image-J software, the villus height was measured from apical tip to the base and 
the crypt depth was measured from the sub-mucosa to the base of the villi. For each 
intestinal sample, at least 10 well-oriented pictures were measured.  
 
Flow cytometry 
For each flow experiment, jejunal epithelial cells were isolated from a pool of 4 mice 
using EDTA/dispase digestion. The cells were fixed in 4% paraformaldehyde for 15 mins 
and resuspended in saponin permeabilisation buffer (Invitrogen, Carlsbad, California, 
USA) with Lyz-FITC (1:10 Dako, Carpenteria, California, USA) for 30 min since Lyz is 
an established marker for PC. Flow analysis was performed per established protocols 4.  
 
Crypt culture 
10 cm segments of jejunum from SPF and GF mice were obtained. These tissues were 
first flushed with 1x PBS, flayed and then cut into 1cm segments, to be placed in tubes 
containing 5 mL of 1x PBS on ice. They were then transferred to another tube containing 
5 mL of 1x PBS and 3.5 mM EDTA (ethylenediaminetetraacetic acid) and placed in the 
cold room on a gentle shaking platform for 20 minutes. The tissues were then moved to 
fresh cold 1x PBS to be manually shaken. The solution was then filtered using a 70 µm 
nylon filter to enrich for crypts. The crypts were then centrifuged at 1000 RPM for 10 
minutes at 4°C. The pelleted crypts were added to Matrigel membrane matrix. They were 
plated with 10 µl of Matrigel crypt mixture per well. The culture conditions used are 
listed in a table in the appendix. The culture was monitored daily, and after six days, 
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several wells of enteroids were pooled and isolated for RNA. The remaining wells were 
then passaged as below. 
 
For sub-epithelial tissue (SET) co-culture experiments, crypts were first isolated from 
jejunum. The remaining tissue, devoid of crypts, was then shaken aggressively to remove 
the epithelium and isolate the SET. 5 cm of the SET was then minced in 200 µL 
phosphate buffered saline and added to the Matrigel  (1.0-2.0 µl of minced SET/ 9 µl of 
Matrigel). Crypts (60-100) were then added to this mixture before plating.  
For assessing the transcript expression level, the SET was stored in 600 µL Buffer RLT 
(Qiagen, Valencia, CA) with 10 µL/mL of B-ME. It was then vortexed and frozen at -80.  
 
Passaging crypt culture 
Media was removed from all the wells and then 200 uL of 1X PBS + 10 µM Y27632 
solution was added to each well. The Matrigel patty was scrapped off the bottom of the 
plate using a P1000 tip. The contents of the well were then aspirated using a 1 mL 
syringe and 31g needle. The contents were next placed into a 15 mL tube and centrifuged 
at 1000 RPM for 10 minutes at 4°C. The pellet was then plated as per primary crypt 
culture. 
 
RNA isolation 
  1) Tissue: Jejunum was placed in a tube containing RNAlater solution for RNA 
isolation and then stored at -80 degrees Celsius. Prior to RNA isolation, tissues were 
homogenized in beta-mercaptoenthanol (BME) and RLT lysis buffer. Total RNA was 
isolated from these samples using a Qiagen MiniKit per manufacturer’s instructions.  
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2) Enteroids: Cultures with enteroids were collected. These enteroids were stored in a 
solution of BME and lysis buffer RLT to inactivate intracellular RNases from degrading 
the RNA. Total RNA was then isolated using the Qiagen MiniKit according to the 
manufacturer’s instructions. After total RNA has been isolated, the quality was evaluated 
using a spectrophotometer and then also running an RNA gel. 
  
Quantitative RT-PCR 
 The expression levels of antimicrobial peptides including lysozyme (Lyz), cryptidin-
related sequence-1c (Crs1c), pan C-reactive protein (Pan-crp), and angiogenin 4 (Ang4) 
and regenerating islet-derived protein 3 gamma (Reg3γ) were evaluated using 
quantitative reverse transcriptase polymerase chain reaction. The primer/probe sets for 
these genes were obtained from Life Technologie. The cDNA of the RNA samples was 
developed using SuperScript II Reverse Transcriptase. Using TaqMan Gene Expression 
Master Mix, the quantitative RT-PCR was performed according to the manufacturer’s 
instructions. The expression level of β-actin was used as a baseline and as an internal 
control since the expression of β-actin is required in all cell types 8. 
 
Statistical analysis 
 The graphical representation of qRT-PCR of the AMP expression levels as well as the 
PC number was done on Graph-Pad Prism 5 (GraphPad, San Diego, California, USA). 
All variables were found to have a normal distribution. Means were compared using 
Student’s t test (2-tailed).  
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RESULTS 
 
Jejunum morphology is impacted by the presence of microbes with variability 
depending on the location 
Previous studies examining the role of microbiota on small intestine development have 
yielded conflicting data. In one study, the villus height and the crypt depth of the small 
intestine increased when exposed to bacteria 13. However, another study presents a 
different data.  Specifically, mice exposed to antibiotics were shown to have increased 
villus height, but decreased crypt depth 9. We hypothesized that the variability in these 
data were in part due to the differential effects of the microbiota on the intestinal 
epithelium within varying locations of the small intestine. To test this, seven GF and 
seven SPF mice were utilized for histological analysis for the jejunal tissue, comparing 
the proximal and distal regions. Figure 4 shows the crypt depth and villus height for GF 
and SPF mice. Panels A and B show histology from the proximal jejunum of SPF and GF 
mice, while panels E and F depict histology from the distal jejunum of SPF and GF mice. 
Quantitative data depicting differences in villus height and crypt depth between SPF and 
GF mice are shown in panels C and D (proximal jejunum) and panels G and H (distal 
jejunum). Note that there is a significant difference in the villus height in both the 
proximal and distal regions of the jejunum when comparing SPF and GF mice. However, 
there is only a significant difference in crypt depth in the proximal jejunum between the 
SPF and GF mice.  
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Figure 4:  H&E stained images of (A,B) proximal (n=16 SPF, n=14 GF) and (E,F) distal jejunum 
(n=7 SPF, n=7 GF). (C, D) Proximal jejunum quantitative analysis for villus height and crypt 
depth. (G,H) Distal jejunum quantitative analysis of for villus height (p=0.0012) and crypt depth. 
*P<0.02 
 
Paneth Cell Number is Decreased in Distal, But Not Proximal Jejunum of Germ-
Free Mice  
Given the clear impact of intestinal location on microbial influences in jejunal 
morphology, we next postulated a similar phenomenon could be relevant to PCs.  To 
explore this further, we examined differences in PC number between GF and SPF mice in 
both proximal and distal regions of the jejunum. Using the same samples mentioned 
earlier, PC numbers were assessed by first identifying crypt-villus units. In Figure 5, 
images A-D show the stained images of proximal and distal regions of GF and SPF mice. 
Panels E and F of Figure 5 are the numerical representations of PC number of GF and 
SPF mice from proximal and distal jejunum. There was a significant decrease in the 
number of PCs in the distal region of the jejunum when GF and SPF mice were 
compared. However, no significant difference was seen in the proximal region.  
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Figure 5: H&E stained images of the crypt structure of proximal jejunum of SPF (A), GF (B) as 
well as distal jejunum of SPF (C) and GF (D) tissues. Quantification of Paneth cell number in 
proximal jejunum (E) with p=0.43 and distal jejunum (F) with ***p=0.0003. 
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Germ-Free Mice Have Fewer Paneth Cells than SPF Mice Across the Entire 
Jejunum 
Having demonstrated that location within the jejunum can affect relative PC numbers 
between SPF and GF mice, we next sought to eliminate this confounder by determining 
PC numbers in the entire jejunum of SPF and GF mice. To do this, we used flow 
cytometery of epithelial cell preparations derived from the whole jejunum. Using this 
approach we quantified the number of lysozyme (Lyz)+ cells in the jejunum of SPF 
versus GF mice. Lyz is an established marker of PCs 4. Figure 6 shows the quantification 
of PCs from the total jejunal tissue in GF and SPF mice.  As demonstrated, GF mice have 
fewer jejunal PCs than their SPF counterparts. 
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Figure 6: The percentage of PCs in the total jejunum from SPF (A) and GF (B) mice. 
PCs are enumerated as Lyz+ cells. Quantification of PC number in the total epithelium 
(C) with p<0.05. The data is obtained from 5 independent experiments with n=4/ mice 
group.  
 
Reg3γ Transcript Expression is Lower in GF Mice, Compared to SPF Mice  
With differences in PC number established earlier, we sought to understand if the mRNA 
expression levels of AMPs were affected by this difference. Figure 7 represents the 
mRNA expression levels of major PC AMP classes from the crypts of SPF and GF 
murine jejunum. The data is obtained from 7 mice from both SPF and GF conditions. 
Only Reg3γ showed a significant difference between these two groups. The transcript 
expression of the other major AMPs did not show any significant differences.  
 
 
 
 
C. 
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Figure 7: Paneth cell mRNA expression levels of major AMPs from crypts of GF and 
SPF mice (n=7 mice/group). *P=0.0006.  
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Reg3γ Expression is Similar in SPF- and GF-Derived Enteroids 
As shown above, in vivo, there was a significant difference in the expression level of 
Reg3γ between SPF and GF mice.  To study the mechanism of this differential 
regulation, we sought to derive an in vitro system that could be used to study which 
factors contribute to these differences. To do this, we turned to the enteroid culture 
system described above.  In Figure 8, Reg3γ expression levels are shown in our enteroid 
in vitro system. Reg3γ transcript levels in freshly isolated crypts are shown first, 
expectedly reproducing our findings in Figure 7A. Reg3γ expression levels are next 
indicated in 6-day old enteroids and enteroids that have been passaged one or two times. 
Remarkably, the Reg3γ expression in SPF enteroids quickly equalizes to that of GF 
enteroids in this culture system, and is maintained at this level after passaging.  
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Figure 8: Reg3γ mRNA expression level in crypts, day 6 enteroids (Day 6 EN) and after 
passaging (PP) 1, and 2. ***P=0.0006 and *P=0.02.  
 
Introduction of Sub-Epithelial Tissue Induces Reg3γ Expression in SPF Enteroids  
As shown in Figure 8, the increased Reg3γ mRNA expression levels in SPF mice 
equilibrates to GF levels in enteroid culture conditions. This provides an ideal setting to 
understand the factors regulating the expression of this AMP. Because the enteroid 
culture system is sterile and devoid of bacteria and bacterial products, we first added 
bacterial ligands such as LPS to the cultured SPF enteroids 1. However, the addition of 
these ligands did not result in the induction of Reg3γ expression. We next hypothesized 
that Reg3γ expression was induced by the stroma underlying the intestinal epithelium, as 
enteroids are cultured solely from the crypt epithelium, and are absent of any such sub-
epithelial tissue. These results are shown in Figure 9. As indicated, Reg3γ mRNA is 
robustly expressed in SPF crypts. However, there is minimal expression in SPF sub-
epithelial tissue and in SPF enteroids.  Remarkably, the addition of SET to the enteroid 
culture saw a significant increase in the Reg3γ expression level compared with SPF 
enteroids alone. These findings suggest the SET plays a key role in inducing Reg3γ 
mRNA expression. 
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Figure 9: Jejunal mRNA expression levels of Reg3γ of crypts, sub-epithelial tissues 
(SET), day 6 enteroids as well as day 6 enteroids co-cultured with the sub-epithelial 
tissue. **P=0.002, ****P<0.0001.  
 
DICUSSION 
 
 Previous studies examining the effects of microbiota on PCs have yielded 
conflicting data. For example, a study done in 1974 by Klockers showed that SPF and GF 
rats had similar PC numbers. However, a separate study by Satoh suggested that GF rats 
had lower PC number when compared to SPF rats 6,12. We hypothesized that these 
conflicting results occurred because different studies examined different locations of the 
small intestine. This hypothesis was validated by showing differences in crypt depth and 
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PC numbers in SPF and GF mice of the distal jejunum, but no such differences between 
groups in the proximal jejunum. Having demonstrated this variability, we chose to 
perform subsequent experiments on the entire jejunum, thereby eliminating the 
confounding variable of proximal versus distal location. Using this new information, we 
have attempted to determine if PCs are regulated by bacteria, their underlying stroma, or 
interactions between both.  
 In this work, we reaffirm the finding that there are differences in expression of the 
PC AMP Reg3γ between mice raised in SPF versus GF conditions. Due to higher Reg3γ 
expression levels in the SPF small intestine relative to GF tissue, we can conclude that 
microbes induce higher transcript expression levels of Reg3γ. Intriguingly, in vitro, 
Reg3γ expression is similar between SPF and GF enteroids. This suggests that something 
present in vivo, but absent in vitro regulates Reg3γ expression. Possibilities for this 
include bacteria and/or the underlying stroma beneath PCs, which we refer to as the sub-
epithelial tissue (SET). 
The equalized Reg3γ levels between the SPF and GF enteroids in culture 
conditions, allows us to study the ability of other factors to induce expression of this 
AMP.  The addition of bacterial ligand such as LPS did not lead to an induction of Reg3γ 
expression in SPF enteroids.  However, the addition of SET to the culture system resulted 
in Reg3γ induction in the SPF enteroids. This suggests that there is signaling from the 
underlying stroma that regulates Reg3γ expression. This will be an important finding for 
investigators using this system to study PC physiology, as they must keep in mind that 
results may not entirely recapitulate the in vivo state.  
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The present study solely focused on the mRNA expression levels of Reg3γ. For 
further assessment of PC function, it will be beneficial to test and compare other 
components. These include assessment of Reg3γ protein levels in the same experimental 
conditions used above. Proteins are the end results of the gene products and hence will 
provide a better understanding of the molecules involved in PC function. Importantly, the 
expression levels of mRNA and proteins may not necessarily correlate since some 
messenger RNA even after transcription might not be translated 5. 
In conclusion, our findings show that PC function, particularly Reg3γ expression, 
is regulated by the sub-epithelial tissue, putatively through signaling from the enteric 
microbiota.  Because the microbiota can be manipulated in patients through interventions 
such as probiotics, antibiotics, and fecal transplantation, it possible that such therapies 
could be used in the future to enhance PC function in patients with Crohn’s disease.  
Thus, based on our present findings, we can develop future studies that will assess which 
particular bacteria are able to influence PC function, and then develop therapies to 
modulate these organisms in patients with Crohn’s disease. 
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APPENDICES 
	
Culture Media Conditions 
 
Reagent Name Supplier Cat. No Stock Solution Final Conc. 
Advanced 
DMEM/ F12 
Invitrogen 12634-028 _ _ 
Hepes, 1M Invitrogen 15630-080 1 M 10 mM 
GlutaMAX Invitrogen 35050-061 100 X 1X 
Gen/Kan Tissue Culture 
Facility 
(Lineberger) 
 100 X 1X 
N2 Supplement Invitrogen 17502-048 100 X 1X 
B27 
Supplement 
Invitrogen 17504-044 50 X 1X 
Growth Factors     
hESC qualified 
Matrigel 
Membrane 
Matrix 
Fisher  _ _ 
Human 
recombinant 
Noggin 
Fisher 1967-NG-025 25 ug 100 ng/mL 
Human 
recombinant R-
spondin 
Fisher 3474-RS-050 50 ug 500 ng/mL 
Human 
recombinant 
EGF 
Fisher 2028-EG-200 200 ug 50 ng/mL 
Crypt Isolation 
Reagents 
    
DPBS Ca2+, 
Mg2+ free 
Tissue Culture 
Facility 
(Lineberger) 
   
EDTA Sigma – Aldrich 431788 .5M 3.5mM 
Passage 
Reagents 
    
Y27632 Sigma Y0503-1mg 1 mg 10 mM 
Reagent Name Supplier Cat. No Stock Solution Final Conc. 
Advanced 
DMEM/ F12 
Invitrogen 12634-028 _ _ 
Hepes, 1M Invitrogen 15630-080 1 M 10mM 
GlutaMAX Invitrogen 35050-061 100X 1X 
Gen/Kan Tissue Culture 
Facility 
 100X 1X 
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(Lineberger) 
N2 Supplement Invitrogen 17502-048 100X 1X 
B27 
Supplement 
Invitrogen 17504-044 50X 1X 
Growth Factors     
hESC qualified 
Matrigel 
Membrane 
Matrix 
Fisher  _ _ 
Human 
recombinant 
Noggin 
Fisher    
Human 
recombinant R-
spondin 
Fisher    
Human 
recombinant 
EGF 
Fisher    
Crypt Isolation 
Reagents 
    
DPBS Ca2+, 
Mg2+ free 
Tissue Culture 
Facility 
(Lineberger) 
   
EDTA Sigma – Aldrich 431788 .5M 3.5mM 
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